PROMIS NEUROSCIENCES INC. Restructuring Reserve, Current
PROMIS NEUROSCIENCES INC. (PMN) had Restructuring Reserve, Current of $79.75 thousand as of 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:RestructuringReserveCurrent · last filed 2026-08-13
- 2025-12-31: Restructuring Reserve, Current $79.75K.
- 2025-09-30: Restructuring Reserve, Current $191.65K.
- 2025-06-30: Restructuring Reserve, Current $303.55K.
- 2025-03-31: Restructuring Reserve, Current $421.52K.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2025-12-31 | $79.75K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $191.65K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $303.55K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $421.52K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $38.33K 10-K · filed 2026-03-25 |
| 2024-09-30 | $172.55K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $287.94K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $403.32K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $518.70K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |